Differential expression and regulation of p53 in human prostatic cells

International Journal of Oncology

Volumn 10, Issue 6, 1997, Pages 1109-1112

  Hsieh, Tze Chen ^a   Wu, Joseph M ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

p53 expression; prostate cancer

Indexed keywords

FENRETINIDE; PROSTATE SPECIFIC ANTIGEN; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING;

EID: 0030949456     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.6.1109     Document Type: Article

References (21)

1. Wingo PA, Tong T and Bolden S: Cancer statistics, 1995. CA Cancer J Clin 45: 8-30, 1995.
2. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF and Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23, 1979.
3. Stone KR, Mickey DD, Wunderli H, Mickey GH and Paulson DF: Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer 21: 274-281, 1978.
4. Muraki J, Addonizio JC, Choudhury MS, Fischer J, Eshghi M, Davidian MM, Shapiro LR, Wilmot PL, Nagamatsu GR and Chiao JW: Establishment of new human prostatic cancer cell line (JCA-1). Urology 36: 79-84, 1990.
5. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosental H, Chu TM, Mirand EA and Murphy GP: LNCaP model of human prostatic carcinoma: Cancer Res 43: 1809-1818, 1983.
6. Levine AJ, Momand J and Finlay CA: The p53 tumor suppressor gene. Nature 351: 453-456, 1991.
7. Donehower LA and Bradley A: The tumor suppressor p53. Biochem Biophys Acta 1155: 181-205, 1993.
8. Furihata M, Sonobe H and Ohtsuki Y: The aberrant p53 protein (Review). Int J Oncol 6: 1209-1226, 1995.
9. Harris CC: Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88: 1442-1455, 1996.
10. Visakorpi T, Kallioniemi OP, Heikkinen A, Koivula T and Isola J: Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. J Natl Cancer Inst 84: 883-887, 1992.
11. Brooks JD, Bova GS, Ewing CM, Piantadosi S, Carter BS, Robinson JC, Epstein JI and Issacs WB: An uncertain role for p53 gene alterations in human prostate cancers. Cancer Res 56: 3814-3822, 1996.
12. Hsieh TC, Ng C and Wu JM: The synthetic retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) exerts antoproliferative and apoptosis-inducing effects in the androgen-independent human prostatic JCA-1 cells. Biochem Mol Biol Int 37: 499-506, 1995.
13. 3 in the androgen-dependent LNCaP cells. Biochem Biophys Res Commun 223: 141-146, 1996.
14. Konno S, Hsieh TC, Wu JM, Chen Y, Chiao JW and Mallouh C: Growth control of human prostatic cancer cells by the phorbol ester TPA: possible involvement of protein kinases. Anticancer Res 16: 1843-1850, 1996.
15. Girinsky T, Koumenis C, Graeber TG, Peehl DM and Giaccia AJ: Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents. Cancer Res 55: 3726-3731, 1995.
16. Carroll AG, Voeller HJ, Sugars L and Gelman EP: p53 oncogene mutations in three human prostate cancer cell lines. Prostate 23: 123-134, 1993.
17. Wang LG, Liu XM, Kreis W and Budman DR: Involvement of prostate specific antigen in the stimulation of LNCaP cell growth. Oncol Rep 3: 911-917, 1996.
18. Wang LG, Liu XM, Kreis W and Budman DR: Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells. Cancer Res 57: 714-719, 1997.
19. Darby E, An S, Ng C, Hsieh TC, Mallouh C and Wu JM: Effects of microtubule inhibitors-taxol, vinblastine and estramustine on the growth and p53 gene expression in the hormone independent human prostatic JCA-1 cells. Anticancer Res 16: 3647-3652, 1996.
20. Yoshimura I, Wu JM, Chen Y, Ng C, Mallouh C, Backer JM, Mendola C and Tazaki H: Effects of 5α-dihydrotestosterone (DHT) on the transcription of nm23 and c-myc genes in human prostatic LNCaP cells. Biochem Biophys Res Commun 208: 603-609, 1995.
21. Ronen D, Schwartz D, Teitz Y, Goldfinger N and Rotter V: Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Differ 7: 21-30, 1996.